Dual anti-thrombotic treatment with direct anticoagulants improves clinical outcomes in patients with Atrial Fibrillation with ACS or undergoing PCI. A systematic review and meta-analysis

BACKGROUND: There is recent new evidence regarding the combined use of direct oral antiocoagulants and antiplatelet agents in patients with Atrial Fibrillation undergoing PCI. PURPOSE: To compare the efficacy of dual antithrombotic treatment (DAT) including a direct oral anticoagulant (DOAC) and an...

Descripción completa

Detalles Bibliográficos
Autores principales: De Rosa, Salvatore, Sabatino, Jolanda, Polimeni, Alberto, Sorrentino, Sabato, Indolfi, Ciro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347192/
https://www.ncbi.nlm.nih.gov/pubmed/32645042
http://dx.doi.org/10.1371/journal.pone.0235511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347192/
https://www.ncbi.nlm.nih.gov/pubmed/32645042
http://dx.doi.org/10.1371/journal.pone.0235511

Ejemplares similares